Publications by authors named "Barry Arnason"

Claim this Profile
I
Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
Xuan Feng, Riyue Bao, Lei Li, Florian Deisenhammer, Barry G W Arnason

EBioMedicine· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Dorothea Buck, Till Fm Andlauer, Wilmar Igl, Eva-Maria Wicklein, Mark Mühlau, Barry Arnason

Mult Scler· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Sven Schippling, Paul O'Connor, Volker Knappertz, Christoph Pohl, Timon Bogumil, Barry Arnason

J Neurol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Kathryn C Fitzgerald, Kassandra L Munger, Karl Köchert, Barry G W Arnason, Giancarlo Comi

JAMA Neurol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Hans-Peter Hartung, Ludwig Kappos, Douglas S Goodin, Paul O'Connor, Massimo Filippi, Barry Arnason

J Neurol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Christian Lampl, Stefan Nagl, Barry Arnason, Giancarlo Comi, Paul O Connor

J Neurol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis.
Barry G Arnason, Regina Berkovich, Anna Catania, Robert P Lisak, Mone Zaidi

Mult Scler· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies.
Hans-Peter Hartung, Bernd Kieseier, Douglas S Goodin, Barry Gw Arnason, Giancarlo Comi

J Neuroinflammation· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Douglas S Goodin, Hans-Peter Hartung, Paul O'Connor, Massimo Filippi, Barry Arnason

Mult Scler· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Nikolaos A Patsopoulos, , , , , Barry G W Arnason

Ann Neurol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives.
Carl E Stafstrom, Barry G W Arnason, Tallie Z Baram, Anna Catania, Miguel A Cortez

J Child Neurol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
David M White, Sabine Pellett, Mark A Jensen, William H Tepp, Eric A Johnson, Barry G W Arnason

Infect Immun· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olig1 is expressed in human oligodendrocytes during maturation and regeneration.
Ahmad Othman, David M Frim, Paul Polak, Snezana Vujicic, Barry G W Arnason

Glia· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Mark A Jensen, Rachel N Yanowitch, Anthony T Reder, David M White, Barry G W Arnason

Mult Scler· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
Paul O'Connor, Massimo Filippi, Barry Arnason, Giancarlo Comi, Stuart Cook, B Arnason

Lancet Neurol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terbutaline in myasthenia gravis: a pilot study.
Betty Soliven, Kourosh Rezania, Betul Gundogdu, Barbara Harding-Clay, Joel Oger, Barry G W Arnason

J Neurol Sci· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Barrie J Hurwitz, Douglas Jeffery, Barry Arnason, Kim Bigley, Patricia Coyle

Clin Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors.
Mark A Jensen, Barry G W Arnason, David M White

Eur J Immunol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and significance of concomitant central and peripheral inflammatory demyelination.
Kourosh Rezania, Barry G Arnason, Betty Soliven

Neurol Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.
Barry G W Arnason

J Neurol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferons in relapsing remitting multiple sclerosis.
Don Paty, Barry Arnason, David Li, Anthony Traboulsee

Lancet· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues and practices in multiple sclerosis.
Jack S Burks, Barry G Arnason, Patricia K Coyle, Corey C Ford, Avertano Noronha

Neurorehabil Neural Repair· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Anne I Boullerne, Jose J Rodriguez, Tarik Touil, Bruno Brochet, Stephan Schmidt, Barry G W Arnason

J Neurosci· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis